Ausdal Financial Partners’s Tiziana Life Sciences TLSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-55,700
| Closed | -$53.5K | – | 592 |
|
|
2024
Q3 | $53.5K | Hold |
55,700
| – | – | 0.01% | 503 |
|
|
2024
Q2 | $51.2K | Hold |
55,700
| – | – | 0.01% | 487 |
|
|
2024
Q1 | $25.3K | Hold |
55,700
| – | – | ﹤0.01% | 462 |
|
|
2023
Q4 | $31.2K | Hold |
55,700
| – | – | ﹤0.01% | 451 |
|
|
2023
Q3 | $36.8K | Sell |
55,700
-1,200
| -2% | -$792 | 0.01% | 427 |
|
|
2023
Q2 | $38.8K | Hold |
56,900
| – | – | 0.01% | 422 |
|
|
2023
Q1 | $62.1K | Hold |
56,900
| – | – | 0.01% | 433 |
|
|
2022
Q4 | $34.1K | Hold |
56,900
| – | – | ﹤0.01% | 440 |
|
|
2022
Q3 | $44K | Hold |
56,900
| – | – | 0.01% | 435 |
|
|
2022
Q2 | $42K | Hold |
56,900
| – | – | 0.01% | 439 |
|
|
2022
Q1 | $60K | Hold |
56,900
| – | – | 0.01% | 472 |
|
|
2021
Q4 | $55K | Buy |
56,900
+10,000
| +21% | +$9.67K | 0.01% | 471 |
|
|
2021
Q3 | $68K | Buy |
46,900
+7,000
| +18% | +$10.1K | 0.01% | 465 |
|
|
2021
Q2 | $94K | Hold |
39,900
| – | – | 0.01% | 450 |
|
|
2021
Q1 | $111K | Buy |
39,900
+13,700
| +52% | +$38.1K | 0.02% | 431 |
|
|
2020
Q4 | $53K | Buy |
26,200
+11,000
| +72% | +$22.3K | 0.01% | 413 |
|
|
2020
Q3 | $51K | Buy |
+15,200
| New | +$51K | 0.01% | 350 |
|